Drug Trial Radar · NCT00158834
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Last checked: Nov 20, 2026Latest source record: Oct 13, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Nov 1999
Primary completion
Not stated
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Sep 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to evaluate if, in children with asthma, a stepwise treatment (five levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed combination of salmeterol and fluticasone propionate 50/500 mcg) based on symptom scores alone results in a sub-optimal treatment when compared to treatment based on cumulative symptom scores and bronchial hyperresponsiveness (PD20 methacholine).
Conditions
- Asthma
Interventions
Salmeterol/Fluticasone propionate combination productDrug
Fluticasone propionateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asthma symptom free days during the last 12 weeks of the treatment period.
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Alkmaar, Netherlands
GSK Investigational Site
Almere Stad, Netherlands
GSK Investigational Site
Amsterdam, Netherlands
GSK Investigational Site
Amsterdam, Netherlands
GSK Investigational Site
Breda, Netherlands
GSK Investigational Site
Eindhoven, Netherlands
GSK Investigational Site
Groningen, Netherlands
GSK Investigational Site
Hilversum, Netherlands
GSK Investigational Site
Leiden, Netherlands
GSK Investigational Site
Maastricht, Netherlands
GSK Investigational Site
Rotterdam, Netherlands
GSK Investigational Site
Sittard, Netherlands
GSK Investigational Site
The Hague, Netherlands
GSK Investigational Site
Utrecht, Netherlands
GSK Investigational Site
Veldhoven, Netherlands
GSK Investigational Site
Zwolle, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.